The BCR–ABL1 fusion protein on the Ph chromosome; a constitutively active tyrosine kinase, has been reported to be the underlying factor in the pathogenesis of CML,2 which leads to perturbation of key signalling pathways resulting in increased proliferation and survival.2, 3. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.